DP-b99 in the Treatment of Acute High-risk Pancreatitis
Status:
Terminated
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Inflammation of the pancreas often leads to severe damage not only to the pancreas but also
to other organs in the abdomen as well as to complications in organs further away like the
lung and the kidney. This trial will examine if DP-b99, given to patients with non-severe
inflammation of the pancreas, can mitigate the development of processes that can lead to
serious complications of this disease.